• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

奎尼丁与普罗帕酮用于房颤转复为窦性心律的比较。

Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.

作者信息

Di Benedetto S

机构信息

Myocardial Infarction Secondary Prevention and Hypertension Unit, S. Orsola-Malpighi Hospital, University of Bologna, Italy.

出版信息

Am J Cardiol. 1997 Aug 15;80(4):518-9. doi: 10.1016/s0002-9149(97)00408-6.

DOI:10.1016/s0002-9149(97)00408-6
PMID:9285671
Abstract

The efficacy and safety of quinidine, as a rapid oral loading therapy, and propafenone in the conversion of atrial fibrillation of <6 months duration to sinus rhythm were compared. Quinidine was more efficacious and as well tolerated as propafenone.

摘要

比较了奎尼丁作为快速口服负荷疗法与普罗帕酮在将持续时间小于6个月的房颤转复为窦性心律方面的疗效和安全性。奎尼丁比普罗帕酮更有效，且耐受性相当。

相似文献

1
Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.奎尼丁与普罗帕酮用于房颤转复为窦性心律的比较。
Am J Cardiol. 1997 Aug 15;80(4):518-9. doi: 10.1016/s0002-9149(97)00408-6.
2
Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.
Am J Cardiol. 1998 Feb 1;81(3):373-4.
3
Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.口服普罗帕酮转复近期发作房颤为窦性心律的安全性：一项前瞻性平行安慰剂对照多中心研究。
Int J Cardiol. 1999 Feb 28;68(2):187-96. doi: 10.1016/s0167-5273(98)00363-5.
4
Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.口服普罗帕酮与奎尼丁作为有症状阵发性心房颤动患者初始治疗选择的比较：一项双盲随机试验。
J Intern Med. 1996 Mar;239(3):253-60. doi: 10.1046/j.1365-2796.1996.451805000.x.
5
Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.口服普罗帕酮与奎尼丁治疗近期发作心房颤动的疗效和耐受性：一项随机、前瞻性研究。
Cardiol J. 2009;16(6):521-7.
6
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm.一项关于口服普罗帕酮与地高辛加奎尼丁转复近期发作房颤为窦性心律的对照研究。
Int J Cardiol. 1994 Mar 1;43(3):305-13. doi: 10.1016/0167-5273(94)90211-9.
7
The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.静脉注射胺碘酮转复慢性心房颤动的疗效。胺碘酮与奎尼丁转复心房颤动的比较。
Arch Intern Med. 1996 Jan 8;156(1):49-53.
8
Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.普罗帕酮用于心房颤动的转复和预防。普罗帕酮心房颤动试验研究人员。
Am J Cardiol. 1997 Feb 15;79(4):418-23. doi: 10.1016/s0002-9149(96)00779-5.
9
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.口服普罗帕酮用于转复有无基础心脏病患者的近期发作房颤：一项随机对照试验。
Ann Intern Med. 1997 Apr 15;126(8):621-5. doi: 10.7326/0003-4819-126-8-199704150-00006.
10
[A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].普罗帕酮与氢奎尼丁口服治疗近期发作心房颤动的比较
Minerva Cardioangiol. 1996 Mar;44(3):141-4.

引用本文的文献

1
Quinidine for Pharmacological Cardioversion of Long-lasting Atrial Fibrillation.奎尼丁用于持续性心房颤动的药物复律
J Atr Fibrillation. 2011 Jul 15;4(2):350. doi: 10.4022/jafib.350. eCollection 2011 Jul-Aug.
2
Cytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.细胞色素P450-2D6基因型定义可能改善阵发性心房颤动的治疗 “口袋药” 奎尼丁加普罗帕酮后晕厥1例
J Atr Fibrillation. 2014 Feb 28;6(5):978. doi: 10.4022/jafib.978. eCollection 2014 Feb-Mar.
3
Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.
在多非利特负荷剂量期间持续性房颤的急性转复不能预测长期无房颤生存。
J Interv Card Electrophysiol. 2015 Mar;42(2):117-24. doi: 10.1007/s10840-015-9974-7. Epub 2015 Jan 27.
4
Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.奎尼丁用于心房颤动的药物复律：对501例连续患者的回顾性分析
Ann Noninvasive Electrocardiol. 2009 Apr;14(2):128-36. doi: 10.1111/j.1542-474X.2009.00287.x.
5
Cost effectiveness of therapies for atrial fibrillation. A review.心房颤动治疗的成本效益。综述。
Pharmacoeconomics. 2000 Oct;18(4):317-33. doi: 10.2165/00019053-200018040-00002.
6
Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.口服普罗帕酮转复近期发作的心房颤动：住院治疗综述
Drugs. 2002;62(3):415-23. doi: 10.2165/00003495-200262030-00001.